Where Will Intuitive Surgical Be in 10 Years?
When it comes to making surgical robots, Intuitive Surgical (NASDAQ: ISRG) is the undisputed king of the hill. Its popular Da Vinci robotic surgical suites are distributed worldwide, and more practitioners are trained on its use every month.
But will its reign last through 2033, or will a challenger threaten its currently cushy position? To answer this question, let's map out this company's next decade.
The first thing to appreciate about Intuitive Surgical is that its penetration of global markets is proceeding at a consistent and sustainable pace that's unlikely to slow anytime soon. In 2022 alone, Da Vinci systems were used to perform more than 1.8 million procedures, bringing the company's lifetime total procedures to above 12 million. To achieve that impressive sum, from 2019 through 2022, its base of installed Da Vinci units grew at a compound annual rate of 12%, most of which was concentrated in the U.S. By 2033, the business's center of gravity may have moved outside the U.S. as it's likely that most of its hardware will be abroad.
Source Fool.com
Vinci S.A. Aktie
Die Vinci S.A. Aktie benötigt mehr Einschätzungen, um ein Sentiment zu bilden.
Für Vinci S.A. sieht die Community ein leicht positives Kursziel von 120 €, verglichen mit dem aktuellen Kurs von 111.1 €.
